Cardiff Oncology Inc (CRDF)

R&D Expense Growth

-12.56%

Quarterly · Period ending:

CRDF logo

CRDF R&D Expense Growth

Latest reported-12.56%
CRDF Quarterly R&D Growth (QoQ) (0.00% → -12.56%)
High-resolution chart · PNG

CRDF r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cardiff Oncology Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-12.5647%
33.3005%
-38.0871%
-29.2142%
10.5278%
7.8769%
0.7469%
1.5485%
18.544%
3.156%
-3.2286%
0.0249%
-11.4008%
40.5154%
7.2059%
-19.3206%
3.3296%
23.7637%
40.2022%
0.8497%
25.6176%
2.4953%
12.055%
15.3069%
-8.4996%
-5.5324%
1.6194%
-0.3949%
6.8328%
6.0873%
36.4152%
-6.2642%
3.659%
56.0761%
-14.6819%
44.1056%
-77.0618%
13.0734%
-3.8705%
-3.4103%
27.0677%
1.3286%
24.3259%
-5.1217%
22.13%
19.7634%
-7.8006%
42.4484%
-3.1437%
12.1678%
40.4804%
-3.0081%
17.651%
35.0581%
16.1442%
7.1847%
41.417%
9.3854%
53.5192%
40.2239%
-44.4655%
161.4324%
0%
-100%
21.0526%
0%
0%
0%
0%
0%
37.7193%
-10.2766%
-52.1257%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.